Cite
HARVARD Citation
Moore, K. et al. (n.d.). 2022-LBA-414-ESGO Preliminary clinical outcome of ADP-A2M4CD8, a next-generation autologous T-cell receptor T-cell therapy, in patients with advanced epithelial ovarian cancer. International journal of gynecological cancer. pp. A472-A473. [Online].